AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS
· Delayed Price · Currency is USD
0.0126
+0.0016 (14.55%)
Mar 6, 2026, 2:50 PM EST
AXIM Biotechnologies Revenue
AXIM Biotechnologies had revenue of $17.48K in the quarter ending June 30, 2024, with 76.04% growth. This brings the company's revenue in the last twelve months to $92.90K, up 257.95% year-over-year. In the year 2023, AXIM Biotechnologies had annual revenue of $39.52K with 345.27% growth.
Revenue (ttm)
92.90K
Revenue Growth
+257.95%
P/S Ratio
49.25
Revenue / Employee
13.27K
Employees
7
Market Cap
4.58M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GPL Holdings | 376.54K |
| Enzon Pharmaceuticals | 26.00K |
| Clearside Biomedical | 3.33M |
| Orgenesis | 899.00K |
| Enzolytics | 46.59K |